Use case sheets

Is this 40–70% lesion flow-limiting? Wire-based FFR is often deferred for time, cost or vessel access reasons, leaving the decision to visual estimation.

Run standard diagnostic projections. Coroview reconstructs the vessel in 3D and computes FFR along its full length, with no wire and no hyperaemic agent.

A per-lesion pullback curve and distal 3D-FFR value for each vessel, available within seconds so treatment can be planned in the same sitting.

The angiogram is unobstructed but symptoms persist. Without thermodilution, microvascular dysfunction goes unmeasured and patients leave without a mechanism.

Virtual IMR is derived from angiographic flow metrics and proximal aortic pressure on the same diagnostic run, alongside 3D-FFR confirming non-obstructive epicardial disease.

A virtual IMR value indicating whether microvascular resistance is raised, supporting an endotype-guided approach to therapy and follow-up.

Acute presentations with non-obstructive arteries need mechanism, but invasive physiology is frequently impractical in the acute setting.

Wire-free analysis of the acute diagnostic angiogram characterises both epicardial flow and microvascular resistance without extra instrumentation or lab time.

Combined 3D-FFR and virtual IMR profile of both coronary systems, informing mechanism-based management and onward investigation.

After successful reperfusion, which patients remain at elevated risk? Microvascular injury drives adverse outcomes but is rarely measured in the acute setting.

Virtual IMR is computed from the post-reperfusion angiogram, requiring no additional wire, adenosine or lab time in an already time-critical procedure.

Patients are stratified by degree of virtual IMR elevation, identifying those with severe microvascular injury who are at higher risk of adverse outcomes and may warrant closer follow-up.